Logo image of NVCN

NEOVASC INC (NVCN) Stock Fundamental Analysis

NASDAQ:NVCN - Nasdaq - CA64065J4037 - Common Stock - Currency: USD

30.03  +0.49 (+1.66%)

Premarket: 29.425 -0.61 (-2.01%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NVCN. NVCN was compared to 189 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of NVCN have multiple concerns. NVCN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NVCN has reported negative net income.
In the past year NVCN has reported a negative cash flow from operations.
NVCN had negative earnings in each of the past 5 years.
NVCN had a negative operating cash flow in each of the past 5 years.
NVCN Yearly Net Income VS EBIT VS OCF VS FCFNVCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -20M -40M -60M -80M -100M

1.2 Ratios

NVCN has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NVCN Yearly ROA, ROE, ROICNVCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 500 -500 1K -1K

1.3 Margins

NVCN's Gross Margin of 79.66% is amongst the best of the industry. NVCN outperforms 90.57% of its industry peers.
NVCN's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for NVCN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 79.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.71%
GM growth 5Y17.59%
NVCN Yearly Profit, Operating, Gross MarginsNVCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -2K -4K -6K

More info and screens

3

2. Health

2.1 Basic Checks

NVCN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NVCN has more shares outstanding
Compared to 1 year ago, NVCN has a worse debt to assets ratio.
NVCN Yearly Shares OutstandingNVCN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M
NVCN Yearly Total Debt VS Total AssetsNVCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -16.71, we must say that NVCN is in the distress zone and has some risk of bankruptcy.
NVCN has a Altman-Z score of -16.71. This is amonst the worse of the industry: NVCN underperforms 87.26% of its industry peers.
A Debt/Equity ratio of 0.81 indicates that NVCN is somewhat dependend on debt financing.
NVCN has a worse Debt to Equity ratio (0.81) than 75.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Altman-Z -16.71
ROIC/WACCN/A
WACC9.15%
NVCN Yearly LT Debt VS Equity VS FCFNVCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M -50M -100M

2.3 Liquidity

A Current Ratio of 2.96 indicates that NVCN has no problem at all paying its short term obligations.
NVCN's Current ratio of 2.96 is in line compared to the rest of the industry. NVCN outperforms 45.28% of its industry peers.
NVCN has a Quick Ratio of 2.85. This indicates that NVCN is financially healthy and has no problem in meeting its short term obligations.
With a Quick ratio value of 2.85, NVCN perfoms like the industry average, outperforming 52.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.96
Quick Ratio 2.85
NVCN Yearly Current Assets VS Current LiabilitesNVCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for NVCN have decreased strongly by -1143.35% in the last year.
NVCN shows a strong growth in Revenue. In the last year, the Revenue has grown by 49.47%.
NVCN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.73% yearly.
EPS 1Y (TTM)-1143.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-121.5%
Revenue 1Y (TTM)49.47%
Revenue growth 3Y22.11%
Revenue growth 5Y-6.73%
Sales Q2Q%91.39%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NVCN Yearly Revenue VS EstimatesNVCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M
NVCN Yearly EPS VS EstimatesNVCN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 -10K -20K -30K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NVCN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NVCN Price Earnings VS Forward Price EarningsNVCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NVCN Per share dataNVCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60 -80 -100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

NVCN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEOVASC INC

NASDAQ:NVCN (4/10/2023, 8:00:02 PM)

Premarket: 29.425 -0.61 (-2.01%)

30.03

+0.49 (+1.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-23 2023-03-23/amc
Earnings (Next)05-10 2023-05-10/amc
Inst Owners14.64%
Inst Owner Change-24.47%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap82.70M
Analysts85.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 21.73
P/FCF N/A
P/OCF N/A
P/B 5.22
P/tB 5.22
EV/EBITDA N/A
EPS(TTM)-105.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-9.07
FCFYN/A
OCF(TTM)-9.05
OCFYN/A
SpS1.38
BVpS5.75
TBVpS5.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 79.66%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.71%
GM growth 5Y17.59%
F-Score3
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.27%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.96
Quick Ratio 2.85
Altman-Z -16.71
F-Score3
WACC9.15%
ROIC/WACCN/A
Cap/Depr(3y)28.29%
Cap/Depr(5y)34.48%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1143.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-121.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)49.47%
Revenue growth 3Y22.11%
Revenue growth 5Y-6.73%
Sales Q2Q%91.39%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.05%
OCF growth 3YN/A
OCF growth 5YN/A